Biotech Values

[DewDiligence]

Heheh… “We conclude that apixaban's dose may be
insufficient to stop clotting and therefore resulted in
less bleeding…” —Cowen analyst, Steve Scala

http://biz.yahoo.com/ap/080827/bristol_myers_squibb_mover.html



<font size=2><font color=red>“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”